An exploratory study on the improvement effect of continuous intake of test food on anemia-related biomarkers. -a open-label, parallel-group comparison trial- - An exploratory study on the improvement effect of continuous intake of test food on anemia-related biomarkers.

IMEQRD Co, Ltd.0 sites60 target enrollmentFebruary 25, 2022

Overview

No summary available.

Registry

who.int

Start Date

February 25, 2022

End Date

April 24, 2022

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

IMEQRD Co, Ltd.

•1\.Currently undergoing treatment for any disease, or receive medical treatment such as medical drugs or traditional Chinese medicines. 2\.Receiving nutritional and exercise therapy under medical doctors. 3\.Have severe diseases or a history of severe diseases. 4\.Have been received GI tract surgery (except for appendicitis). 5\.Have currently been taking commercially available drugs, quasi\-drug products, foods, or supplements with any functional claims. However, can discontinue taking these drugs/foods during the trial period is acceptable to join the study. 6\.Have an allergy to drugs, or foods. 7\.Planning extremely change lifestyle (such as diet, sleep, or exercise) during the study period. 8\.Work in shift and night shift. 9\.Planning travel to foreign countries during the study period. 10\.Currently pregnant or breastfeeding, or planning to pregnant during the study period. 11\.Take more than 60 g alcohol/day. 12\.Smoker (more than 21 cigarettes/day). 13\.Donated blood (including plasma or serum) more than 200 mL within three months before the study. 14\.Individuals who joined other clinical trials from one month before the trial, individuals who have currently been joined other clinical trials, and also individuals who are planning to join other clinical trials during the trial. 15\.Unsuitable for this study, that judged by the principal investigator.